title: Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients.
authors.forename: S
authors.initials: S
authors.lastname: Teramoto
authors.forename: Y
authors.initials: Y
authors.lastname: Yamaguchi
authors.forename: H
authors.initials: H
authors.lastname: Yamamoto
authors.forename: Y
authors.initials: Y
authors.lastname: Hanaoka
authors.forename: M
authors.initials: M
authors.lastname: Ishii
authors.forename: S
authors.initials: S
authors.lastname: Hibi
authors.forename: T
authors.initials: T
authors.lastname: Ishii
authors.forename: H
authors.initials: H
authors.lastname: Kume
authors.forename: Y
authors.initials: Y
authors.lastname: Ouchi
mesh_terms: D001823:Body Composition; D002319:Cardiovascular System; D045422:Continuous Positive Airway Pressure; D006801:Humans; D007249:Inflammation; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000150:complications; D009765:Obesity / Q000150:complications*; D010919:Placebos; D012737:Sex Factors; D020181:Sleep Apnea, Obstructive / Q000150:complications*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D010919:Placebos